A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not treg/tr1-type responses

Mohan Karkada, Genevieve M. Weir, Tara Quinton, Leeladhar Sammatur, Lisa D. Macdonald, Alecia Grant, Robert Liwski, Ridas Juskevicius, Gomathinayagam Sinnathamby, Ramila Philip, Marc Mansour

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)
Original languageEnglish
Pages (from-to)250-261
Number of pages12
JournalJournal of Immunotherapy
Volume33
Issue number3
DOIs
Publication statusPublished - Apr 2010

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology
  • Cancer Research

Fingerprint

Dive into the research topics of 'A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not treg/tr1-type responses'. Together they form a unique fingerprint.

Cite this

Karkada, M., Weir, G. M., Quinton, T., Sammatur, L., Macdonald, L. D., Grant, A., Liwski, R., Juskevicius, R., Sinnathamby, G., Philip, R., & Mansour, M. (2010). A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not treg/tr1-type responses. Journal of Immunotherapy, 33(3), 250-261. https://doi.org/10.1097/CJI.0b013e3181c1f1e9